Since nowadays detailed genetic determination experiments involving noncancer tissue types are not used in routine cancer diagnostics, further such studies are required to reveal the frequency of de novo BRCA1/2 mutations and their contribution to carcinogenesis. This evidence concerns the gene BRCA1 and cancer.